Minor
LFD-200 in Healthy Adults and · Moderate to Severe Rheumatoid Arthritis
Trial sites expanded: 7 → 10 locations
Lifordi Immunotherapeutics, Inc.Phase 1 NCT07207954 Registry history of NCT07207954 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 7 → 10 locations
Lifordi Immunotherapeutics, Inc.Phase 1 NCT07207954 Registry history of NCT07207954 on ClinicalTrials.gov (opens the registry)
| Phase 1 | 1 |